Bastiaan Jeroen van der Baan

This profile gathers the share dealings of Bastiaan Jeroen van der Baan in Lixte Biotechnology Holdings, Inc. Between 30 December 2022 and 3 October 2023, the trades on record add up to 3 filings.

No open-market sale appears; the market trades are 3 purchases worth €77k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 3 purchases and no sales.

A typical purchase (the median) is worth €27k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 5 October 2023 with an open-market purchase (€27k) in Lixte Biotechnology Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.